Myriad Genetics is a leading molecular diagnostic company dedicated to saving and improving lives by discovering and delivering tests across major diseases. In this project we compiled the dossier of information for the clinical genetic test, Endopredict©.
Following an initial literature review we designed and drafted the entire dossier. This test uses a multigenic system to analyse the level of risk of breast cancer. It is the first second generation analysis that can be performed in any laboratory, with both short and long term high predictive capacity.
The test is easy to use and understand, with clear results.
- Technical translation